1 | single copy integration site | | | | | | | 3 | 1.24% |
2 | copy integration site technology | | | | | | | 3 | 1.24% |
3 | abcheck meeting your needs | | | | | | | 2 | 0.83% |
4 | humanization single copy integration | | | | | | | 2 | 0.83% |
5 | a part of ampersand | | | | | | | 2 | 0.83% |
6 | releases company presentation contact | | | | | | | 2 | 0.83% |
7 | press releases company presentation | | | | | | | 2 | 0.83% |
8 | biomedicines view press release | | | | | | | 2 | 0.83% |
9 | view press release abcheck | | | | | | | 2 | 0.83% |
10 | binders gpcrs mhcipeptide complexes | | | | | | | 2 | 0.83% |
11 | adcs binders gpcrs mhcipeptide | | | | | | | 2 | 0.83% |
12 | technologies rabbit mass humanization | | | | | | | 2 | 0.83% |
13 | meeting your needs in | | | | | | | 2 | 0.83% |
14 | technology stateoftheart antibody discovery | | | | | | | 2 | 0.83% |
15 | is now a part | | | | | | | 2 | 0.83% |
16 | integration site technology stateoftheart | | | | | | | 2 | 0.83% |
17 | rabbit mass humanization single | | | | | | | 2 | 0.83% |
18 | who we are careers | | | | | | | 2 | 0.83% |
19 | about us our approach | | | | | | | 2 | 0.83% |
20 | discovery and development abcheck | | | | | | | 2 | 0.83% |
21 | our approach who we | | | | | | | 2 | 0.83% |
22 | approach who we are | | | | | | | 2 | 0.83% |
23 | now a part of | | | | | | | 2 | 0.83% |
24 | technologies microfluidics rabbit mass | | | | | | | 2 | 0.83% |
25 | theart antibody discovery technologies | | | | | | | 2 | 0.83% |
26 | imprint technologies microfluidics rabbit | | | | | | | 2 | 0.83% |
27 | microfluidics rabbit mass humanization | | | | | | | 2 | 0.83% |
28 | leaders in antibody discovery | | | | | | | 1 | 0.41% |
29 | unique technology solutions and | | | | | | | 1 | 0.41% |
30 | technology solutions and stateoftheart | | | | | | | 1 | 0.41% |
31 | trusted leaders in antibody | | | | | | | 1 | 0.41% |
32 | technologies technologies we are | | | | | | | 1 | 0.41% |
33 | solutions and stateoftheart antibody | | | | | | | 1 | 0.41% |
34 | integration site technology technologies | | | | | | | 1 | 0.41% |
35 | antibody discovery technologies technologies | | | | | | | 1 | 0.41% |
36 | technologies microfluidics technologies rabbit | | | | | | | 1 | 0.41% |
37 | stateof theart antibody discovery | | | | | | | 1 | 0.41% |
38 | microfluidics technologies rabbit mass | | | | | | | 1 | 0.41% |
39 | rabbit mass humanization technologies | | | | | | | 1 | 0.41% |
40 | technologies single copy integration | | | | | | | 1 | 0.41% |